AstraZeneca has resumed British clinical trials of its experimental coronavirus vaccine, one of the most advanced in development, after receiving the green light from safety watchdogs
The late-stage trials of the experimental vaccine, developed with researchers from the University of Oxford, were suspended this week after an illness in a study subject in Britain, casting doubts on an early rollout.
The patient involved in the study had been reportedly suffering from neurological symptoms associated with a rare spinal inflammatory disorder called transverse myelitis.“The Company will continue to work with health authorities across the world and be guided as to when other clinical trials can resume to provide the vaccine broadly, equitably and at no profit during this pandemic,” AstraZeneca said.
The vaccine is in late-stage clinical trials in the United States, Britain, Brazil and South Africa and additional trials are planned in Japan and Russia.The pause of the trials came after reports that the United States was aiming for fast-track authorization or approval of a vaccine before November’s presidential election.
The WHO’s chief scientist said the pause in the trials should serve as a “wake-up” call that there would be ups and downs in the development of a vaccine.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
AstraZeneca Covid-19 Vaccine Trials Resume in U.K.The company has ended a pause in clinical trials for its experimental coronavirus vaccine in the U.K. after regulators concluded it was safe to do so. The trials were halted globally after a person who received the vaccine had an unexplained illness.
Weiterlesen »
AstraZeneca Resumes Its COVID-19 Vaccine Trials In The U.K.The company had placed its worldwide vaccine trials on hold for several days. It now says a safety review by regulators and reviewers is complete. No word on when studies in the U.S. might resume.
Weiterlesen »
Why AstraZeneca pausing its COVID-19 vaccine trial may be good newsAstraZeneca has temporarily put the brakes on its late-stage, global COVID-19 vaccine trial after a participant came down with what experts call an 'adverse event.' The promising vaccine candidate created by researchers at Oxford had been marching through rounds of clinical trials before word
Weiterlesen »
Merck starts recruitment for COVID-19 vaccine trialU.S. drugmaker Merck & Co Inc has begun recruiting participants to its early-stage COVID-19 vaccine study, according to the government database clinicaltrials.gov.
Weiterlesen »
Pfizer, BioNTech propose expanding COVID-19 vaccine trial to 44,000 volunteersPfizer Inc and BioNTech SE have proposed to the U.S Food and Drug Administration (FDA) to expand the enrollment of their Phase 3 pivotal COVID-19 vaccine trial to up to about 44,000 participants, the companies said on Saturday.
Weiterlesen »